Prospective Cohort Study With Risk-adapted Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma
We dichotomize patients according to the risk of CNS involvement. Then, we perform CNS
evaluation in patients at risk of CNS involvement. We prospectively monitor whether CNS
relapse or metastasis occurs in patients with diffuse large B-cell lymphoma
Interventional
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
CNS relapse/involvement
After enrollment, patients will be monitored to check the CNS relapse or involvement
Up to 2 years after participants are enrolled.
No
Cheolwon Suh, MD, PhD
Principal Investigator
Consortium for Improving Survival of Lymphoma
Korea: Institutional Review Board
2010-04-091
NCT01202448
August 2010
December 2014
Name | Location |
---|